The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes.

The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes. - The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019018

Enrollment

168

Registered

2015-09-14

Start date

2014-12-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes and non diabetes patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Subjects with FPG <180 mg/dl (2)Subjects who have not been administered insulin or insulin resistance improving drug four weeks before admission. (3)Subjects who have never recieved treatment of osteoporosis (4)Subjects who give consent document about participation in the clinical study

Exclusion criteria

Exclusion criteria: (1) With diabetic ketoacidosis, diabetic coma and type 1 diabetes (2) With an abnormality in the endocrine hormone levels (3)With severe infections (4)Subjects who have administered melatonin or melatonin receptor agonist (5)Subjects with cognitive decline (less than 23 points in the MMSE). (6)Subjects With malignancy within 5 years (7) Considered as inadequate by the investigator

Design outcomes

Primary

Measure	Time frame
Correlation between melatonin and glucose metabolism in type 2 diabetes and non-diabetic patients	—

Countries

Japan

Contacts

Public Contactkenichi tanaka

University of Occupational and Environmental Health, Japan First Department of Internal Medicine, School of Medicine

kenichi.tanaka0801@gmail.com093-603-1611

Outcome results